Addressing challenges for sustainable healthcare in Central and Eastern Europe

ABSTRACT

All European countries face increasing challenges in the provision of equitable and comprehensive healthcare for their citizens in view of a number of factors. These include changing demographics and the continual launch of new premium priced medicines. The challenges are even more difficult among Central and Eastern European healthcare systems. Consequently, there is a need for countries to learn from each other to help address some of these challenges and to maintain sustainable systems. This was the basis of the 2-day conference, The Fifth International Conference: Challenges for Efficient Healthcare in Central and Eastern Europe, 9-10 October 2015, Belgrade, Serbia.

KEYWORDS:

• Serbia
• HTA
• patient registries
• orphan medicines
• biosimilars

The Fifth International Conference: Challenges for Efficient Healthcare in Central and Eastern EuropeBelgrade, Serbia,9–10 October 2015

Declaration of interest

The conference was sponsored by MSD, ZEM Solutions, Arcana Institute, HTA Consulting, Roche, Abbvie, Novartis, Pharmaswiss and Galenika; however, the sponsors had no involvement in the development of this article and the views expressed represent those of the authors’ alone. The write-up of this paper was in part supported by the Karolinska Institutet, Sweden. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.